Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Slow Release DHEA in Asthma
NCT07179952Phase 2Not yet recruiting
- Sponsor
- Indiana University
- Start
- Jan 2027
- Primary completion
- Sep 2028
- Modality
- Allosteric Modulators
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Slow Release DHEA with Placebo (2 arms). Primary endpoints: Asthma Control Test up to 94 days and Asthma Control Questionnaire up to 94 days. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
dehydroepiandrosterone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07179952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07179952.